MAXLINEAR, INC·4

May 5, 4:11 PM ET

ARTUSI DANIEL A 4

4 · MAXLINEAR, INC · Filed May 5, 2026

Research Summary

AI-generated summary of this filing

Updated

MaxLinear (MXL) Director Daniel A. Artusi Exercises RSUs, Sells 10,500 Shares

What Happened

  • Daniel A. Artusi, a director of MaxLinear, had 15,741 restricted stock units (RSUs) convert into common shares on May 1, 2026 (reported as an exercise/conversion of a derivative). The filing also reports a derivative disposition of 15,741 shares on the same date (reported at $0.00). He then sold 10,500 shares in the open market on May 4, 2026 for an aggregate $825,728 (weighted average price $78.64).

Key Details

  • Transaction dates and prices:
    • May 1, 2026: Exercise/conversion of 15,741 RSUs into shares (reported at $0.00).
    • May 1, 2026: Derivative disposition of 15,741 shares at $0.00 (per the filing).
    • May 4, 2026: Open-market sale of 10,500 shares, weighted average price $78.64 (range $78.60–$78.76), total proceeds $825,728. (Footnote F1: the filing will provide per-price breakdown on request.)
  • Footnotes:
    • F2/F3: Each RSU equals one share; 100% of the RSUs vested on May 1, 2026.
    • F1: Sale price is a weighted average of shares sold within $78.60–$78.76.
  • Shares owned after the transaction: Not specified in the provided Form 4 excerpt.
  • Filing timeliness: Form 4 was filed May 5, 2026 covering transactions dated May 1 and May 4; no late filing is indicated in the report.

Context

  • The primary activity was RSU vesting and conversion (a non-cash award becoming shares), followed by an open-market sale of part of the shares. For retail investors, sales after RSU vesting are often routine (to cover taxes or diversify) rather than a standalone bearish signal; the filing is factual and does not state the insider’s motivation.

Insider Transaction Report

Form 4
Period: 2026-05-01
Transactions
  • Exercise/Conversion

    Common Stock

    2026-05-01+15,74127,882 total
  • Sale

    Common Stock

    [F1]
    2026-05-04$78.64/sh10,500$825,72817,382 total
  • Exercise/Conversion

    Restricted Stock Units

    [F2][F3]
    2026-05-0115,7410 total
    Common Stock (15,741 underlying)
Footnotes (3)
  • [F1]Represents the weighted average share price of an aggregate total of 10,500 shares sold in the price range of $78.60 to $78.76 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock.
  • [F3]One hundred percent (100%) of the RSUs subject to the award vested on May 1, 2026.
Signature
/s/ Connie Kwong, as Attorney-in-Fact|2026-05-05

Documents

1 file
  • 4
    wk-form4_1778011891.xmlPrimary

    FORM 4